| 2008 - 2013 |
NIH NHLBI Research Grant, R01 HL089315 ,
“Angiogenic Tissue Engineering to Limit Post-Infarction
Ventricular Remodeling”. |
| |
|
| 2004 - 2009 |
NIH NHLBI/Thoracic Surgery Foundation for Research
and Education jointly sponsored Mentored Clinical Scientist
Development Award, 1 K08 HL072812, “Angiogenesis
and Cardiac Growth as Heart Failure Therapy.” |
| |
|
| 2006 - 2008 |
American Heart Association Beginning Grant-in-Aid,
0665441U, “Endogenous Myocardial Revascularization
and Repair via Endothelial Progenitor Cell Chemokinesis.” |
| |
|
| 2005 - 2008 |
Cardiogenesis Corp. “Molecular and Cellular Characterization
of Neovasculogenesis in Transmyocardial Revascularization.” |
| |
|
| 2004 - 2006 |
American Heart Association Beginning Grant-in-Aid,
0465519U, “Targeted Endothelial Progenitor Cell
Chemokinesis as Vasculogenic Therapy for Ischemic Cardiomyopathy” |
| |
|
| 2003 - 2007 |
Myocor Inc. “Randomized Evaluation of a Surgical
Treatment for Off-Pump Repair of the Mitral Valve.” |
| |
|
| 2005 - 2006 |
Clinical Therapeutics Inc. “ A Randomized, Double-Blind,
Placebo-Controlled, Parallel-Group, Multicenter, Proof
of Concept Clinical Study of CTI-1(Ethyl Pyruvate) in
Patients Undergoing Major Cardiac Surgery with Cardiopulmonary
Bypass (CTI-1-C04-201 Phase II) |
| |
|
| 2002-2003 |
Intuitive Surgical Inc. “Totally Endoscopic Coronary
Artery Bypass Grafting with the da Vinci Robotic System.” |
| |
|
| 2002-2003 |
Thomas B. McCabe and Jeanette Laws McCabe Fund Fellowship
“Angiogenic Strategies for the Treatment of Heart
Failure.” |
